Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients

I. Gross; K.M. Trentino; A. Andreescu; R. Pierson; R.A. Maietta; Shannon Farmer

Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients

I. Gross, K.M. Trentino, A. Andreescu, R. Pierson, R.A. Maietta, Shannon Farmer

Research output: Contribution to journal › Article

Abstract

© AlphaMed Press 2016. Background. Patient blood management (PBM) programs are associated with reduced transfusion usage, reduced hospital costs, and improved patient outcomes.The application of PBM principles in patients with malignant disease might achieve similar results. However, this population presents unique challenges. The aim of the present study was to investigate the impact of a PBM program on blood usage and patient outcomes in cancer patients, particularly in the setting of restricted use of erythropoiesis-stimulating agents (ESAs). Materials and Methods. A retrospective observational study was performed of patients admitted with a primary diagnosis of malignancy treated at Eastern Maine Medical Center as inpatients or outpatients, or both, from January 2008 through July 2013. Results. The proportion of inpatients and outpatients receiving ESAs decreased from 2.9% in 2008 to 1.1% in 2013 (p

Original language	English
Pages (from-to)	327-332
Journal	ONCOLOGIST
Volume	21
Issue number	3
Publication status	Published - 2016

Fingerprint Dive into the research topics of 'Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients'. Together they form a unique fingerprint.

Cite this

@article{59a837c87a8e466ea52dcabf5ca3a479,

title = "Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients",

abstract = "{\textcopyright} AlphaMed Press 2016. Background. Patient blood management (PBM) programs are associated with reduced transfusion usage, reduced hospital costs, and improved patient outcomes.The application of PBM principles in patients with malignant disease might achieve similar results. However, this population presents unique challenges. The aim of the present study was to investigate the impact of a PBM program on blood usage and patient outcomes in cancer patients, particularly in the setting of restricted use of erythropoiesis-stimulating agents (ESAs). Materials and Methods. A retrospective observational study was performed of patients admitted with a primary diagnosis of malignancy treated at Eastern Maine Medical Center as inpatients or outpatients, or both, from January 2008 through July 2013. Results. The proportion of inpatients and outpatients receiving ESAs decreased from 2.9% in 2008 to 1.1% in 2013 (p",

author = "I. Gross and K.M. Trentino and A. Andreescu and R. Pierson and R.A. Maietta and Shannon Farmer",

year = "2016",

language = "English",

volume = "21",

pages = "327--332",

journal = "ONCOLOGIST",

issn = "1083-7159",

publisher = "Alphamed Press",

number = "3",

}

TY - JOUR

T1 - Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients

AU - Gross, I.

AU - Trentino, K.M.

AU - Andreescu, A.

AU - Pierson, R.

AU - Maietta, R.A.

AU - Farmer, Shannon

PY - 2016

Y1 - 2016

N2 - © AlphaMed Press 2016. Background. Patient blood management (PBM) programs are associated with reduced transfusion usage, reduced hospital costs, and improved patient outcomes.The application of PBM principles in patients with malignant disease might achieve similar results. However, this population presents unique challenges. The aim of the present study was to investigate the impact of a PBM program on blood usage and patient outcomes in cancer patients, particularly in the setting of restricted use of erythropoiesis-stimulating agents (ESAs). Materials and Methods. A retrospective observational study was performed of patients admitted with a primary diagnosis of malignancy treated at Eastern Maine Medical Center as inpatients or outpatients, or both, from January 2008 through July 2013. Results. The proportion of inpatients and outpatients receiving ESAs decreased from 2.9% in 2008 to 1.1% in 2013 (p

AB - © AlphaMed Press 2016. Background. Patient blood management (PBM) programs are associated with reduced transfusion usage, reduced hospital costs, and improved patient outcomes.The application of PBM principles in patients with malignant disease might achieve similar results. However, this population presents unique challenges. The aim of the present study was to investigate the impact of a PBM program on blood usage and patient outcomes in cancer patients, particularly in the setting of restricted use of erythropoiesis-stimulating agents (ESAs). Materials and Methods. A retrospective observational study was performed of patients admitted with a primary diagnosis of malignancy treated at Eastern Maine Medical Center as inpatients or outpatients, or both, from January 2008 through July 2013. Results. The proportion of inpatients and outpatients receiving ESAs decreased from 2.9% in 2008 to 1.1% in 2013 (p

M3 - Article

VL - 21

SP - 327

EP - 332

JO - ONCOLOGIST

JF - ONCOLOGIST

SN - 1083-7159

IS - 3

ER -